Evidence map›Paper›PMID 42865749›Full record

ArticleScience China. Mathematics2026

Network-based hierarchical heterogeneity analysis and applications to cancer omics data.

Ruiyue Wang, Sanguo Zhang, Shuangge Ma

Abstract read
In one paragraph

Article in Science China. Mathematics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ruiyue WangSchool of Mathematical Sciences, University of Chinese Academy of Sciences, Beijing 100049, China.
Sanguo ZhangSchool of Mathematical Sciences, University of Chinese Academy of Sciences, Beijing 100049, China.
Shuangge MaDepartment of Biostatistics, Yale University, New Haven, CT 06510, USA.

Funding

Novel methods for identifying genetic interactions in cancer prognosisR01CA204120 · NCI · YALE UNIVERSITY · PI Shuangge Ma · 2016 to 2026
$3.5M
NCI NIH HHS R01 CA204120
6 · The paper itself

Abstract

In the study of complex diseases, heterogeneity analysis has been routinely conducted. A series of recent studies have suggested that network (graph)-based heterogeneity analysis can take a system perspective and be more informative than that based on simpler statistics such as mean and variance. In this article, we conduct Gaussian graphical model (GGM)-based heterogeneity analysis. Significantly advancing from the existing literature, we consider the scenario, where measurements can be decomposed into two parts, with the first and second parts for a rough grouping and a refined subgrouping, respectively. Additionally, the groups and subgroups have a nested structure, which enhances interpretability. A penalization approach is developed for simultaneous sparse estimation, grouping and subgrouping, and achieving the hierarchical structure. Its theoretical properties are rigorously established, and an effective computational algorithm is developed. Simulation demonstrates its competitive empirical performance. The analysis of data from the Pan-Cancer Analysis of Whole Genomes (PCAWG) further demonstrates its practical utility and leads to sensible findings.

Indexed as

62F1262H3062J07cancer omics dataGaussian graphical modelheterogeneity analysishierarchynetwork analysis

Identifiers

PMID42865749
PMCPMC13655714

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.